Initial Treatment for COPD Exacerbation
Immediately initiate short-acting inhaled beta2-agonists (SABAs) combined with short-acting anticholinergics (SAMAs), systemic corticosteroids (prednisone 40 mg daily for 5 days), and antibiotics when indicated by the presence of increased sputum purulence. 1
Bronchodilator Therapy (First-Line Treatment)
Administer SABA plus SAMA together as initial therapy for all COPD exacerbations, as this combination provides superior bronchodilation compared to either agent alone, with effects lasting 4-6 hours. 1, 2, 3
- Delivery method: Either nebulizer or metered-dose inhaler with spacer can be used effectively, though nebulizers are preferred in sicker hospitalized patients because they are easier to use and don't require coordination of 20+ inhalations needed to match nebulizer efficacy. 2
- Dosing schedule: Administer upon arrival, then every 4-6 hours, but may be used more frequently if needed. 1
- Avoid methylxanthines (theophylline) due to increased side effects without added benefit. 2
Systemic Corticosteroids (Essential Component)
Administer prednisone 40 mg orally once daily for exactly 5 days starting immediately. 1, 2, 4
- Oral administration is equally effective to intravenous and should be the default route unless the patient cannot tolerate oral intake. 2
- Do not exceed 5-7 days duration - longer courses provide no additional benefit and increase cumulative steroid exposure by over 50%. 1, 2
- Corticosteroids improve lung function, oxygenation, shorten recovery time and hospitalization duration, and prevent recurrent exacerbations within the first 30 days. 1, 2, 4
Antibiotic Therapy (When Indicated)
Prescribe antibiotics for 5-7 days if the patient has all three cardinal symptoms (increased dyspnea, increased sputum volume, increased sputum purulence) OR two cardinal symptoms with increased sputum purulence as one of them. 1, 2, 4
- First-line antibiotics: Amoxicillin, tetracycline, or amoxicillin-clavulanate for mild to moderate exacerbations. 1, 4
- Alternative options: Macrolides or fluoroquinolones based on local bacterial resistance patterns. 1
- For Pseudomonas risk factors: Consider ciprofloxacin. 4
- Antibiotics reduce short-term mortality by 77%, treatment failure by 53%, and sputum purulence by 44%. 2
Oxygen Therapy (Critical for Hypoxemic Patients)
Target SpO2 of 88-92% (or 90-93%) using controlled oxygen delivery to avoid CO2 retention. 2, 4, 5
- Initial FiO2 should not exceed 28% via Venturi mask or 2 L/min via nasal cannula until arterial blood gases are known in patients with known COPD aged 50 years or older. 1, 4
- Mandatory arterial blood gas measurement within 1 hour of initiating oxygen to assess for worsening hypercapnia. 2
Respiratory Support for Severe Exacerbations
Initiate noninvasive ventilation (NIV) immediately as first-line therapy for patients with acute hypercapnic respiratory failure who have no absolute contraindications. 1, 2, 4, 5
- NIV improves gas exchange, reduces work of breathing, decreases need for intubation, shortens hospitalization duration, and improves survival. 1, 2, 4
Common Pitfalls to Avoid
- Do not extend corticosteroid duration beyond 5-7 days - no additional benefit and significantly increased adverse effects. 1, 2
- Do not withhold oxygen out of fear of CO2 retention - instead, use controlled delivery and monitor with arterial blood gases. 2, 5
- Do not prescribe antibiotics for all exacerbations - only when cardinal symptoms indicate bacterial infection to avoid unnecessary antibiotic exposure. 1, 2
- Do not use theophylline - increased side effects without added benefit compared to standard bronchodilators. 2